rs1799817 — INSR His1085His

Synonymous variant in the tyrosine kinase domain of the insulin receptor; the A risk allele (plus-strand) is associated with PCOS susceptibility and insulin resistance in lean women, possibly through altered mRNA processing near the ATP-binding site of the receptor kinase domain

See your personal result for INSR

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Insulin Receptor's Silent Gatekeeper — INSR His1085His

The insulin receptor is the master switch for glucose metabolism. When insulin binds to its extracellular alpha subunit, it triggers a conformational change that activates the intracellular beta subunit's tyrosine kinase domain — initiating a cascade that opens glucose transporters, suppresses glucose production, and directs energy storage. Variants in the tyrosine kinase domain, even synonymous ones that don't change the amino acid sequence, can subtly alter how this switch operates.

rs1799817 (His1085His) is a C→T transition on the coding strand of exon 17, which encodes part of the catalytic kinase domain. On the plus strand used by genome files, the alleles are G (reference) and A (alternate). Despite producing no amino acid change, this variant sits adjacent to the ATP-binding site critical for receptor autophosphorylation — the event that initiates insulin signaling.

The Mechanism

Synonymous variants in coding regions were long assumed to be functionally inert. More recently, evidence has accumulated that so-called silent polymorphisms11 silent polymorphisms
Silent variants can influence mRNA secondary structure, codon usage, and exon splicing enhancer sequences — all of which alter the efficiency of protein translation and the final level of functional receptor at the cell surface. can perturb mRNA processing, codon translation efficiency, or splicing enhancer elements22 splicing enhancer elements
Exonic splicing enhancers (ESEs) are short consensus sequences within exons that recruit splicing factors. A synonymous SNP that disrupts an ESE can cause exon skipping or intron retention, potentially altering the reading frame or domain composition of the final protein. within exon 17.

The H1085 position is located near the ATP-binding cleft of the INSR tyrosine kinase domain. While the substitution of one histidine codon for another (CAC→CAT) does not change the amino acid, it may alter local mRNA secondary structure and translational speed, potentially affecting the co-translational folding of the kinase domain. The downstream consequence — proposed in multiple studies — is increased serine phosphorylation of the receptor, a modification that competitively inhibits tyrosine autophosphorylation and blunts post-receptor insulin signaling.

The Evidence

The most consistent finding across studies is an association between the A allele (coding-strand T; rs1799817) and PCOS risk, particularly in lean women.

A 2020 Saudi Arabian case-control study33 2020 Saudi Arabian case-control study
Alnaaim et al. RS1799817 in INSR associates with susceptibility to polycystic ovary syndrome. Int J Clin Pract. 2020. PMID:33033446 (126 PCOS cases, 118 controls) found the T allele significantly enriched in PCOS women (allele frequency 0.306 vs. 0.174 in controls, p<0.001). The relative risk was 2.82 in heterozygotes, with the association most pronounced in lean PCOS women who had elevated HOMA-IR.

An Indian cohort study (Vasan et al. 202044 Vasan et al. 2020
Vasan et al. Association of GWAS identified INSR variants with PCOS in Indian women. Int J Biol Macromol. 2020. PMID:31837364) showed OR 11.8 (95% CI 6.3–22.3) for PCOS among T allele carriers (n=240), with significantly higher serum insulin and testosterone levels in the risk-allele group.

Earlier work by Mukherjee et al. 200955 Mukherjee et al. 2009
Mukherjee et al. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with PCOS. Eur J Endocrinol. 2009. PMID:19211708 showed that C/T heterozygotes in lean PCOS women had significantly higher HOMA-IR and free androgen index compared to C/C homozygotes — the key functional connection between the INSR variant and the PCOS phenotype.

However, the picture is not uniform. A 2021 meta-analysis66 2021 meta-analysis
Cao et al. Replication study and meta-analysis of selected genetic variants and polycystic ovary syndrome susceptibility in Asian population. J Assist Reprod Genet. 2021. PMID:34403018 pooling 3,635 participants across 15 Asian studies found no statistically significant association in the overall pooled analysis — though individual studies in Korean and Chinese subsets showed significant effects. This heterogeneity likely reflects differences in PCOS diagnostic criteria, BMI stratification, and population structure across studies.

Practical Actions

The primary clinical implication of this variant is for women in whom standard PCOS screening may be warranted. The variant is associated most strongly with insulin resistance in lean women — a presentation of PCOS that is frequently missed because insulin resistance is often assumed to require obesity.

Fasting insulin and HOMA-IR77 HOMA-IR
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) = fasting insulin (µIU/mL) × fasting glucose (mmol/L) ÷ 22.5. Values above 2.0-2.5 are typically considered indicative of insulin resistance. monitoring provides a non-invasive window into whether receptor signaling is impaired, regardless of body weight.

Interactions

rs1799817 is in moderate linkage disequilibrium with rs2059807, another INSR variant that tags the same GWAS signal identified in Han Chinese populations. Carrying both risk alleles compounds the signal at the INSR locus. The INSR locus interacts with the THADA locus (rs13429458) in PCOS GWAS — these represent independent pathways (insulin receptor signaling vs. Ca²⁺ channel/thyroid adenoma-associated gene), and women with risk variants at both loci show additive increases in metabolic syndrome prevalence.

Genotype Interpretations

What each possible genotype means for this variant.

GG Common Genotype Normal

Standard insulin receptor function at this locus

You carry two copies of the G (reference) allele at rs1799817, corresponding to the common C/C genotype on the coding strand of the INSR tyrosine kinase domain. This is the most common genotype globally (~62% of people) and is associated with standard insulin receptor signaling at this position.

No specific action is indicated by this genotype. The insulin receptor is not compromised at this locus.

AG Heterozygous Carrier Intermediate

One risk allele — modestly elevated PCOS and insulin resistance risk

The His1085His synonymous variant sits within exon 17, adjacent to the ATP-binding cleft of the insulin receptor's beta-subunit kinase domain. Despite no amino acid change, this region contains exonic splicing enhancer sequences and may influence local mRNA secondary structure. The proposed result is increased serine phosphorylation of the receptor, which inhibits tyrosine autophosphorylation — the activation event for downstream insulin signaling.

In heterozygotes, one allele retains the common C nucleotide, which may partially buffer the effect. The association with PCOS is most evident in lean women (BMI <25) where insulin resistance is less explained by adiposity and more attributable to receptor-level dysfunction.

AA Homozygous Risk High Risk

Two risk alleles — elevated PCOS risk and insulin resistance

Homozygosity for the A allele at rs1799817 places both copies of the insulin receptor gene in the minor-allele configuration within exon 17's tyrosine kinase domain. At the molecular level, the proposed mechanism is increased serine phosphorylation of the insulin receptor, which competitively inhibits the tyrosine autophosphorylation required for full receptor activation. The net result is reduced IRS-1 (insulin receptor substrate 1) tyrosine phosphorylation and downstream attenuation of PI3K/Akt and MAPK signaling.

In lean women with PCOS, this receptor-level inefficiency — rather than excess adipose tissue — may be the primary driver of compensatory hyperinsulinemia, which in turn stimulates ovarian androgen production and disrupts follicle development. The Mukherjee et al. 2009 study found that INSR exon 17 variant carriers had significantly higher free androgen index and HOMA-IR even after controlling for BMI.

The T2D and NAFLD data are less clear-cut and may reflect different metabolic contexts: in some studies the T allele appears protective for NAFLD (possibly because lean insulin resistance does not drive hepatic fat accumulation the same way adipose insulin resistance does).